Treatment of Enterococcus Urinary Tract Infections with Amoxicillin
Amoxicillin is an appropriate first-line treatment for urinary tract infections caused by ampicillin-sensitive Enterococcus species, as it is specifically FDA-approved for genitourinary tract infections due to susceptible Enterococcus faecalis. 1
Rationale for Using Amoxicillin
- Amoxicillin is FDA-approved for "infections of the genitourinary tract due to susceptible (ONLY β-lactamase–negative) isolates of Enterococcus faecalis" 1
- When Enterococcus is confirmed sensitive to ampicillin, amoxicillin is an appropriate choice due to:
- Similar mechanism of action (both are aminopenicillins)
- Equivalent efficacy in urinary tract infections
- Better oral absorption compared to ampicillin
- Convenient dosing schedule
Dosing and Duration
- For uncomplicated lower UTIs:
- For complicated UTIs or pyelonephritis:
- Consider extending treatment to 7-14 days 2
Evidence Supporting Efficacy
Recent research confirms that aminopenicillins (including amoxicillin) are non-inferior to non-aminopenicillin antibiotics for treating enterococcal lower UTIs, with clinical success rates of 83.1% for aminopenicillins versus 82.0% for non-aminopenicillins 3. This study demonstrated efficacy even in cases where susceptibility testing was not performed.
Important Clinical Considerations
Advantages of Amoxicillin
- Oral bioavailability
- Established safety profile
- Cost-effectiveness
- Specific FDA approval for enterococcal UTIs
Potential Limitations
- Ineffective against β-lactamase-producing organisms
- Not appropriate for patients with severe penicillin allergies
Alternative Options
If amoxicillin cannot be used (due to allergy or resistance), consider:
- Nitrofurantoin (100mg twice daily for 5 days) for uncomplicated lower UTIs 2
- Fosfomycin (3g single dose) for uncomplicated lower UTIs 2
- For resistant strains, consult infectious disease specialists for guidance on alternative agents such as linezolid or daptomycin 4
Follow-up Recommendations
- Consider follow-up urine culture 1-2 weeks after completing therapy if symptoms persist 2
- If bacteriuria recurs, select an alternative agent rather than repeating the same antibiotic 2
Key Pitfalls to Avoid
Do not use cephalosporins: Enterococci have intrinsic resistance to cephalosporins, making these ineffective regardless of in vitro susceptibility results 2
Distinguish colonization from infection: Avoid unnecessary treatment of asymptomatic bacteriuria, which is common with Enterococcus, particularly in catheterized patients 4
Consider local resistance patterns: While ampicillin sensitivity generally predicts amoxicillin sensitivity, local resistance patterns should inform empiric therapy choices 2
Verify species identification: E. faecalis is generally more susceptible to antibiotics than E. faecium, which may require different treatment approaches 2